147.52USD-0.05%Mkt Cap: 183.02B $P/E: —Today
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, D…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap183.02B $
Enterprise Value199.14B $
Revenue (TTM)30.46B $
Gross Profit23.21B $
Net Income (TTM)8.51B $
Revenue/Share24.51 USD
Last Price147.52 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS3755581036
Valuation
P/E (Trailing)—
P/E (Forward)14.50
PEG2.14
EV/EBITDA13.64
EV/Revenue6.54
P/S5.84
P/B15.05
EPS (TTM)-2.58
EPS (Forward)9.89
52W Range
108.4680% of range157.29
52W High157.29 USD
52W Low108.46 USD
Profitability
Gross Margin78.83%
Oper. Margin33.68%
EBITDA Margin47.94%
Profit Margin28.90%
ROE37.49%
ROA14.42%
Growth
Revenue Growth10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.02B $
CapEx (TTM)563.00M $
FCF Margin32.07%
FCF Yield5.34%
Net Debt21.36B $
Net Debt/EBITDA1.46
Balance Sheet
Debt/Equity1.10
Current Ratio1.26
Quick Ratio0.90
Book Value/Sh9.532 USD
Cash/Share3.937 USD
Dividends
Fwd Div Rate3.280 USD
Trail. Div Rate3.220 USD
Div. Yield2.22%
5Y Avg Yield3.57%
Payout Ratio43.40%
Ex-Div DateSep 15, 2026
Pay DateSep 29, 2026
Splits
Last Split2:1
Split DateJan 28, 2013
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)157.41 USD
Upside (mean)+6.7%
Target Range123.00 USD – 180.00 USD
$123.00+6.7% to mean$180.00
# Analysts27
Ownership
Shares Out.1.24B
Float1.24B
Insiders0.11%
Institutions92.42%
Short Interest
Short Ratio3.6d
Short % Float1.97%
Short % Out.1.97%
Shares Short24.39M
Short (prev mo.)25.48M
Technical
SMA 50131.41 (+12.3%)
SMA 200132.94 (+11.0%)
Beta0.34
S&P 52W Chg18.16%
Avg Vol (30d)6.13M
Avg Vol (10d)5.81M
Technical Indicators
RSI (14)73.6
MACD2.7271
MACD Signal1.5344
MACD Hist.+1.1927
BB Upper142.67 USD
BB Middle133.98 USD
BB Lower125.28 USD
BB Width12.97%
ATR (14)4.232 USD
Vol Ratio (20d)1.08x